MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Progressive supranuclear palsy(PSP)"

  • 2022 International Congress

    COMBINED CSF α-SYN RT-QuIC, CSF NFL AND MIDBRAIN-PONS PLANIMETRY IN DEGENERATIVE PARKINSONISMS: FROM BEDSIDE TO BENCH, AND BACK AGAIN

    C. Painous, M. Soto, M. Pulido-Salgado, M. Fernández, A. Camara, V. Sánchez, N. Bargallo, N. Caballol, C. Pont-Sunyer, M. Buongiorno, N. Martin, M. Basora, M. Tio, D. Giraldo, A. Pérez-Soriano, I. Zaro, E. Muñoz, MJ. Marti, F. Valldeoriola, Y. Compta (Barcelona, Catalonia)

    Objective: (1) to assess the combined diagnostic ability of CSF NFL, CSF RT-QuIC α-SYN and midbrain/pons MRI measures in degenerative parkinsonisms; (2) to interpret results…
  • 2022 International Congress

    Cognitive and Psychiatric Correlates of Fear of Falling in Progressive Supranuclear Palsy and Multiple System Atrophy

    V. Martinez-Villota, C. Terroba-Chambi Chambi, S. Castillo-Torres, M. Rossi, M. Merello (Buenos Aires, Argentina)

    Objective: To evaluate the clinical correlates of fear of falling (FoF) in patients with Progressive Supranuclear Palsy (PSP) and Multiple System Atrophy (MSA) Background: FoF…
  • 2022 International Congress

    Probable Four-repeat tauopathy criteria in Corticobasal Syndrome: diagnostic accuracy, clinical features and imaging biomarkers

    J. Parmera, C. Carneiro, M. Oliveira, P. Barbosa, C. Buchpiguel, R. Nitrini, E. Barbosa, S. Brucki, A. Coutinho (São Paulo, Brazil)

    Objective: To compare the “probable four-repeat (4R)-tauopathy” criteria[1] with the clinical research(cr) criteria for corticobasal degeneration (CBD) [2] regarding diagnostic accuracy to predict a negative…
  • 2022 International Congress

    Effects of venlafaxine on neuropsychiatric and motor symptoms in patients with progressive supranuclear palsy

    M. Zeitzschel, M. Maheu, T. Donner, C. Gerloff, A. Gulberti, M. Pötter-Nerger (Hamburg, Germany)

    Objective: This prospective, ongoing, interventional trial is related to the ProPSP registry and aims to characterize the effects of venlafaxine, a serotonin-norepinephrine reuptake inhibitor, on…
  • 2022 International Congress

    Variability in Age of Onset, Age of Diagnosis and Age of Death for Progressive Supranuclear Palsy Patients Among Three Racial Groups in Hawai`i

    A. Kannan, F. Gao, G. Fujikami, M. Bruno (Honolulu, USA)

    Objective: To examine if differences in age of symptom onset, age of diagnosis, age of death, and number of years lived after diagnosis exist for…
  • 2022 International Congress

    Explorative study of analysis of the role of NFL and IGF1 in Indian patients with PSP and its clinical correlation.

    R. Yelamanchi, S. Dey, R. Yadav, P. Pal, M. Debnath, V. Holla, N. Kamble, S. T N, T. Mullapudi (Bangalore, India)

    Objective: In this prospective cross sectional case control study, we have investigated the relationship of serum levels of Neurofilament light chain and Insulin like growth…
  • MDS Virtual Congress 2021

    Automated Midbrain-Pons Ratio using Artificial Intelligence Differentiates PSP from other Atypical Parkinsonian Disorders

    M. Peres, G. Leroy, A. Gerhard, M. Hu, J. Klein, P. Leigh, A. Church, D. Burn, H. Morris, J. Rowe, T. Rittman (Cambridge, United Kingdom)

    Objective: Our primary goal was to implement an automated measure of the midbrain to pons ratio (MPR) using an artificial intelligence method. Our second objective…
  • MDS Virtual Congress 2021

    A retrospective review of clinical features of Progressive Supranuclear Palsy (PSP) in a movement disorders clinic

    G. Shepherd, T. Wongwarawipat, A. Chatterjee (Reading, United Kingdom)

    Objective: Understanding the common clinical features of PSP. Background: PSP is a relatively rare progressive neurodegenerative disease, which can often be difficult to distinguish from…
  • MDS Virtual Congress 2021

    Backward Fall Protection Garment for patients of PSP and other Parkinsonian Syndromes.

    H. Singh, D. Singhal, N. Sawal, A. Beri, S. Kumar, G. Hundal, A. Chawla (Chandigarh, India)

    Objective: To create a sensor controlled wearable system with an inflatable collar that offers protection against head, spine and shoulder girdle injuries in case of…
  • MDS Virtual Congress 2021

    Neuroimaging associations to gait impairments in progressive supranuclear palsy

    I. Sintini, K. Kaufman, S. Loushin, H. Botha, P. Martin, M. Senjem, R. Reid, C. Schwarz, C. Jack, V. Lowe, K. Josephs, J. Whitwell, F. Ali (Rochester, USA)

    Objective: The aim of this study was to determine how multimodal imaging biomarkers were related to abnormalities in three-dimensional motion-based gait and balance measurements in…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 42
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley